|
Volumn 30, Issue 5, 1998, Pages 2232-2233
|
Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
INOLIMOMAB;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG INDICATION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
TREATMENT OUTCOME;
VIRUS REPLICATION;
ANTIBODIES, MONOCLONAL;
ANTILYMPHOCYTE SERUM;
CYCLOSPORINE;
GRAFT REJECTION;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER CIRRHOSIS;
LIVER FUNCTION TESTS;
LIVER TRANSPLANTATION;
MYCOPHENOLIC ACID;
RECURRENCE;
RETROSPECTIVE STUDIES;
RNA, VIRAL;
TIME FACTORS;
VIRUS REPLICATION;
|
EID: 0031691205
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00602-2 Document Type: Conference Paper |
Times cited : (29)
|
References (14)
|